№ lp_2_3_63172
File format: docx
Character count: 12373
File size: 90 KB
Tier two service specification outlining the provision, enrolment pathways, exclusions, and treatment processes for community oral health services for children and adolescents, including preventive care, diagnostics, and restorative procedures.
Year:
2021
Region:
New Zealand
Topic:
Oral Health Services for Children and Adolescents
Document Type:
Service Specification
Organization:
Ministry of Health
Target Audience:
District Health Boards, oral health practitioners
Previous Versions:
October 2004, June 2015
Next Review:
within five years
Status:
Approved, Mandatory
Contact:
Service Specification Programme Manager, Planning and Accountability, Ministry of Health, [email protected]
Source:
Nationwide Service Framework Library (NSFL)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Authors:
Brendan J. McMullan; Anita J. Campbell; Christopher C. Blyth; Jonathan C. McNeil; Christopher P. Montgomery; Steven Y. C. Tong; Asha C. Bowen
Type of document:
Narrative review article
Topic:
Pediatric Staphylococcus aureus bacteremia
Population:
Neonates, children and adolescents
Medical specialty:
Infectious Diseases
Methods:
Systematic appraisal of published literature
Data sources:
PubMed and Medline
Search period:
January 1960 – 31 December 2018
Geographic context:
High-income countries
Funding source:
No funding received
Conflict of interest:
None declared
Clinical scope:
Community-acquired and healthcare-associated bacteremia
Year:
2023
Region / City:
Canberra, Australia
Topic:
Paediatric intravenous extravasation management
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Expert clinical reference groups
Target Audience:
Clinicians in paediatric care
Period of validity:
Ongoing
Approval Date:
7 December 2023
Amendment Date:
26 August 2024
Clinical Commissioning Policy Tenofovir alafenamide for treatment of HIV 1 in adults and adolescents
Year:
2025
Region / City:
England
Theme:
HIV Treatment, Antiretroviral Therapy
Document Type:
Policy Statement
Organization / Institution:
NHS England
Author:
NHS England
Target Audience:
Healthcare professionals, policy makers
Effective Period:
Ongoing from May 2025
Approval Date:
May 2025
Date of Last Update:
August 2025
Year:
2021
Region:
England
Subject:
HIV-1 treatment
Document type:
Clinical commissioning policy
Organization:
NHS England
Target audience:
Adults and adolescents living with HIV-1
Approved date:
2021
Drug reviewed:
Tenofovir alafenamide (TAF)
Treatment context:
Antiretroviral therapy (ART)
Purpose:
Funding and clinical guidance for TAF use
Evidence reviewed:
Comparative safety and efficacy versus TDF
Population:
Patients with contraindications to TDF or with complications during treatment
Year:
2025
Region / City:
Canberra
Topic:
Medical Procedures, Oncology, Hematology
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Author:
Canberra Health Services
Target Audience:
Healthcare professionals involved in chemotherapy administration
Effective Period:
Ongoing
Approval Date:
2025-01-01
Date of Changes:
2025-01-01
Year:
2024
Region / city:
Canberra, ACT
Theme:
Asthma, Paediatrics, Clinical Guidelines
Document Type:
Clinical Guideline
Organization / institution:
Canberra Health Services
Author:
Paediatric Improvement Collaborative (PIC)
Target Audience:
Healthcare professionals, Paediatricians, Clinical staff
Effective period:
Indefinite
Approval date:
21/11/2024
Amendment date:
21/11/2024
Superseded document:
CHS21/253 Acute Asthma - Paediatrics (infants, children and adolescents)
Acknowledgment:
Ngunnawal people as traditional custodians of the ACT
Context:
Clinical guideline for the assessment and management of paediatric asthma within the Canberra Health Services Network.
Year:
2023
Region / City:
Canberra
Topic:
Behavioral Health, Pediatric Care
Document Type:
Procedure
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical and healthcare professionals, specifically those in Emergency Department and Mental Health Services
Period of Application:
Ongoing, as part of interim procedure
Approval Date:
Not specified
Date of Changes:
Not specified
Organization:
Canberra Health Services
Type of document:
Clinical guideline
Topic:
Dental fissure sealants and fissure protection
Population:
Children and adolescents
Target audience:
Dental practitioners
Region:
Australia
Healthcare sector:
Oral health services
Clinical focus:
Caries prevention and early intervention
Materials covered:
Resin-based sealants; glass ionomer cement sealants
Scope of application:
Public oral health services
Evidence base:
Research studies and professional guidelines
Includes procedures:
Yes
Includes risk assessment:
Yes
Includes attachments:
Yes
Year:
2023
Region / City:
Canberra
Topic:
Pediatric Tube Feeding
Document Type:
Guideline
Organization / Institution:
Canberra Health Services Network
Author:
Canberra Health Services Policy Team
Target Audience:
CHS Network clinicians, pediatricians, and families of patients under pediatric care
Action Period:
Ongoing
Approval Date:
14/07/2023
Amendment Dates:
22/03/2024, 05/08/2024
Year:
2023
Region / city:
Canberra
Topic:
Medical Procedure, Bleeding Disorders
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Author:
Canberra Health Services
Target Audience:
Medical and nursing staff involved in desmopressin administration
Period of validity:
Ongoing
Approval Date:
2023
Date of changes:
N/A
Note:
Year
Region / City:
Canberra
Subject:
Stoma care, Post-operative care
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Target Audience:
Healthcare professionals involved in stoma care
Description:
Procedure document for the management of patients with a stoma in Canberra Health Services, including pre-operative education, post-operative care, and various stoma-related issues across different patient groups.
Year:
2019
Region / City:
N/A
Topic:
Behavioral Health Services for Children and Adolescents
Document Type:
Service Description
Organization:
N/A
Author:
N/A
Target Audience:
Healthcare Providers, Caregivers, Policy Makers
Effective Period:
Starting 7/1/2019
Approval Date:
N/A
Amendment Date:
N/A
Year:
2023
Region / City:
USA
Topic:
Hypertriglyceridemia, Genetic Disorders, Pediatrics
Document Type:
Research Article
Author:
Amy S. Shah, MD, MS, FNLA, Don P. Wilson, MD, FNLA
Target Audience:
Medical professionals, researchers, healthcare providers
Effective Period:
2023
Approval Date:
February 22, 2023
Date of Modifications:
N/A
Year:
2021
Region/Institution:
University of Wisconsin, University of Minnesota, University of Connecticut, University of Maryland, USA
Document Type:
Supplementary material
Authors:
Guanmin Liu, Na Zhang, Jia Yuan Teoh, Christine Egan, Thomas A. Zeffiro, Richard J. Davidson, Karina Quevedo
Corresponding Author:
Karina Quevedo, [email protected]
Target Population:
Depressed adolescents and healthy controls
Study Method:
fMRI, Emotional Self-Other Morph-Query (ESOM-Q) task, behavioral measures
Sample Size:
81 depressed youth, 37 healthy controls
Variables Measured:
Depression severity, self-compassion, response time, accuracy, fMRI activity
Demographics:
Age, sex, race/ethnicity, puberty stage, household income, parental marital status
Medication Use:
Antidepressant, antipsychotic, mood stabilizer, stimulant, anxiolytic
Year:
2024
Region / City:
Malawi
Subject:
Education, Infrastructure Development, Environmental and Social Management
Document Type:
Report
Organization / Institution:
Government of the Republic of Malawi, Ministry of Education
Author:
Government of Malawi
Target Audience:
Government officials, education sector stakeholders, contractors
Implementation Period:
December 2021 – December 2025
Approval Date:
February 2024
Revision Date:
February 2024
Note:
Study Summary 1.1 Please provide a brief summary of the study in the table below. A complete description of the study with detailed information should be provided in the body of the protocol. For sections not applicable to the study, mark them as N/A. Study Title Study Design Primary Objective/Purpose Secondary Objective(s)/Purposes Research Intervention(s) ClinicalTrials.gov NCT # Study Population Sample Size Study Duration for individual subjects Study Specific Abbreviations/ Definitions
Background 3.1 Provide the scientific or scholarly background for, rationale for, and significance of the research based on the existing literature and how will it add to existing knowledge. :
this section should be limited to only information directly related to the research questions and objectives. Do not include your full dissertation proposal. 3.2 Describe any relevant preliminary data (e.g. pilot data).
Procedures Involved 5.1 Describe and explain the study design. 5.2 Please select the methods that will be employed in this study (select all that apply):
☐ Audio/Video Recording ☐ Psychophysiological Recording ☐ Behavioral Interventions ☐ Record Review - Educational ☐ Behavioral Observations and Experimentations ☐ Record Review - Employee ☐ Deception ☐ Record Review- Medical ☐ Focus Groups ☐ Record Review - Other ☐ Interviews ☐ Specimen Collection or Analysis ☐ Investigational Medical Device – (e.g. Medical Mobile Applications) ☐ Surveys and/or Questionnaires ☐Psychometric Testing ☐ Other Social-Behavioral Procedures Provide a description of all research procedures being performed and when they are performed. (Upload any surveys, questionnaires, interview scripts, focus group scripts, debriefing scripts, psychometric tests, stimulus materials, intervention manuals, and data collection forms on the Local Site Documents page in the IRB application.) 5.3 Describe the procedures or interventions that are going to be conducted as part of the research project, but that would have been conducted anyway, even if the research was not occurring (i.e. standard of care procedures, activities that would occur in a classroom). 5.4 Describe the procedures performed to lessen the probability or magnitude of risks of items selected in 5.2.5. 5 If accessing or collecting existing data, describe: The data that will be collected during the study (e.g. demographics, medical history, etc.). Attach the data capture sheet(s) on the Local Site Documents page in the IRB application. How the data will be obtained, including how you have the authority to access the data. The source or location of the data (e.g. USF Epic, TGH Epic, Hillsborough County School records, CANVAS records, publicly available databases, etc.). 5.6 If collecting and/or analyzing biological specimens, describe: How the biological specimens will be or have been collected. How the biological specimens will be stored. How long the biological specimens will be stored. How the biological specimens will be used. The laboratories that will be used. Whether the collected biological specimens will undergo genetic testing. If so, indicate if this study is part of a Genome Wide Association Study (GWAS) and whether the data will be forwarded to the NIH dbGaP. 5.7 If there are plans for long-term follow-up (once all research related procedures are complete), what data will be collected during this period.
Data and Specimen Storage for Future Research 6.1 If data or specimens will be banked for future research studies, describe where the data or specimens will be stored, how long it/they will b:
the process to request a release, approvals required for release, who can obtain data or specimens, and the data to be provided with specimens.
) and join the S1NET. For guides with in depth examinations of performance measure definitions, go to:
https://www.milsuite.mil/book/docs/DOC-129783
Table of Contents (Hyperlinks to Sections):
Developing ‘Significant Duties and Responsibilities’ OER Narratives: Notes, Rules, and Instructions OER Narrative Prohibited Techniques, Inconsistencies, No-Go’s: Negative Comment Rules Referred OERs Narrative Comment Examples Block a. APFT and HT/WT Block b. Overall Performance Block c. Character (to include SHARP comments) Block d. Presence Block e. Intellect Block f. Leads Block g. Develops Block h. Achieves Senior Rater Potential Senior Rater Narrative Examples Senior Rater Narrative Comment Examples (for potential, promotion, school, etc.) Successive Assignments Other SR Comments (explanations of anything unusual about OER) Effective Words for Evaluations JUNIOR OFFICER PLATE (DA FORM 67-10-1) NOTE: 2LTs who have NOT completed BOLC, will not receive an OER until they complete BOLC (AC and ARNG; USAR officers can receive an OER before completing BOLC). The FROM date will be their commissioning date. All time until their BOLC graduation will be NONRATED on their first OER. OER PROFILING: OERs: Rater and Senior Rater Profiles are CONSTRAINED, meaning Officers are only allowed to grant 49% of each rank they rate with either an “EXCELS” (as Rater) or “MOST QUALIFIED” (as Senior Rater). HOWEVER, if you have an immature profile, and have only just begun rating/senior rating Officers of a certain rank, you are allowed a ONE TIME option of giving one of the first two evaluations you make at a particular grade, an “EXCELS” (as Rater) or “MOST QUALIFIED” (as Senior Rater). OER (OER SUPPORT FORM) PART III: Developing ‘Significant Duties and Responsibilities’ (blocks a., b., and c.): Refer to DA PAM 611-21 (https://www.milsuite.mil/book/groups/smartbookdapam611-21
) and DA PAM 600-3 (Commissioned Officer Professional Development and Career Management), to assist in the development of PART III, block d. As a minimum, the duty description will include pr:
- Number of personnel supervised, - Amount of resources under the rated officer’s control, - Scope of responsibilities. 3) Descriptions must be clear and concise with emphasis on specific functions required. 4) Note conditions unique to the assignment; e.g. RA officers assigned to FT support duties with RC units or USAR officers assigned to RA units OER NARRATIVES: Notes, Rules, and Instructions Rater and Senior Rater Narratives: - Requires candor and courage; frank and accurate assessment. - Quantify officer’s value relative to peers and do so in concert with rater/senior rater box check. - Are short; tell a simple story about the quality of officer being evaluated. - Are interesting and compelling. - Are looked at by selection board members when they are looking for in-depth information about a rated officer’s performance and potential. - Numbers; 1-10, write them out (e.g. one, two, ten). 11 or higher, write the number; e.g. 11, 15, 105. Exception, when a 1-10 is WITH an 11 or higher; e.g. “5 tool kits with 20 tools each.” - Fashion the narrative to the officer; double check use of “he/his” vs. “she/hers.” - Awards: Awards and/or special recognition received during the rating period may be cited in evaluation comments (for example, “received the Humanitarian Service Medal” or “named the Instructor of the Year”). - Raters and SR CAN use the officer’s name in the narrative; e.g. “1LT Joe was ….” Rater and Rater Narratives: - Focus on PERFORMANCE; explaining what the rated officer did and how well he/she did it. - Focus on specifics to quantify and qualify performance. - Raters should advocate the rated officer to the SR. - When there is no SR (due to lack of qualifications), rater’s narrative provides the input on both performance and potential. Senior Rater (SR) and SR Narrative (see SR Rater Narrative section for examples): - Focus on POTENTIAL, 3-5 years out (promotions, command, school, & assignments). - Can amplify box checks by using the narrative to clearly send the appropriate message to selection boards. - CANNOT mention Box Check. - Additional information for when SR is also Rater can be found in DA PAM 623-3, pg. 26, “DA Form 67–10–1, part VI: block c—Senior Rater Narrative.” OER Narrative Prohibited Techniques, Inconsistencies, No-Go’s: - School/Course Comments: Bullets about how a Soldier did in a school or course are ONLY allowed if that school did not produce an AER/DA Form 1059. - Narratives are not a laundry list of superlatives – more is not necessarily better. - Brief, unqualified superlatives or phrases, particularly if they may be considered trite. - Excessive use of technical acronyms, or phrases not commonly recognized. - Techniques aimed at making specific words, phrases, or sentences stand out from the rest of the narrative; e.g. excessive use of capital letters; unnecessary quotation marks; repeated use of exclamation points; wide spacing between selected words, phrases, or sentences to include double spacing within a paragraph or between paragraphs. - Inappropriate references to box checks; e.g “Would be TOP BLOCK if profile allowed” or “absolutely far exceeded the standard”. - Trying to quantify (e.g. “top 2% of my captains”) with a small population. - Stay in your lane/level; avoid comments like “Best 1LT in the Army” unless you’re the Army CoS. - Stating “the best ever”; having 10 in the population, 50 in the profile. - Using overused phrases and clichés that are counterproductive or overused; e.g. stellar, historic, “delivered a dazzling performance,” “hit the ground running,” consummate professional, and unlimited potential. - Using specific selection board-type language. Examples of this include, “definitely a 6+ Soldier”. - Don’t exaggerate; “If I could prove it, CPT X is an LTC disguised as a CPT.” - Be mindful of what IS NOT said; it can have the same impact as what is said; e.g. NOT having numbers, or quantifiable points. - Don’t say the sa
Note:
en
Topic:
Officer Evaluation, Narrative Guidelines
Document Type:
Guide
Target Audience:
Raters, Senior Raters
Year:
2020
Region / city:
Johns Hopkins University
Topic:
Coronavirus, Medical Research, Virus Characteristics
Document type:
Informational Article
Organization / institution:
Johns Hopkins University
Author:
Irene Ken
Target audience:
General Public, Researchers
Period of validity:
Ongoing
Date of approval:
4/3/2020
Date of changes:
N/A
Year:
2022
Region / City:
Beijing, China
Topic:
Neutronics, Fusion Energy, Tritium Breeding Ratio
Document Type:
Research Paper
Organization / Institution:
CAEP Software Center for High Performance Numerical Simulation, Institute of Applied Physics and Computational Mathematics
Authors:
Xin Wang, Rui Li, Yuanguang Fu, Guiming Qin, Li Deng, Xueming Shi
Target Audience:
Researchers and Engineers in Fusion Energy
Period of Action:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Acknowledgement:
Sponsored by National MCF Energy R&D Program (No. 2022YFE03160001)
Note:
References
Li Deng, Gang Li, Bao-Yin Zhang, et al., A High Fidelity General Purpose 3-D Monte Carlo Particle Transport Program JMCT 3.0, Nuclear Science and Techniques, 33:
108 (2022)
Wang, X., Li, JL., Wu, Z. et al., CMGC:
A CAD to Monte Carlo Geometry Conversion Code, NUCL SCI TECH 31, 82 (2020)